These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 9361949)
1. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60. Xenos EX; Ciancio G; Burke GW; Roth D; Miller J Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949 [TBL] [Abstract][Full Text] [Related]
2. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
3. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. Ciancio G; Burke GW; Suzart K; Roth D; Kupin W; Rosen A; Olson L; Esquenazi V; Miller J Transplantation; 2002 Apr; 73(7):1100-6. PubMed ID: 11965039 [TBL] [Abstract][Full Text] [Related]
4. Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. Chkhotua AB; Klein T; Shabtai E; Yussim A; Bar-Nathan N; Shaharabani E; Lustig S; Mor E Urology; 2003 Dec; 62(6):1002-6. PubMed ID: 14665344 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689 [TBL] [Abstract][Full Text] [Related]
6. Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. Ciancio G; Miller A; Burke GW; Gharagozloo H; Rosen A; Roth D; Kupin W; Pinna A; Cespedes M; Esquenazi V; Miller J Transplant Proc; 2001; 33(1-2):1013-4. PubMed ID: 11267169 [No Abstract] [Full Text] [Related]
7. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience. Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911 [No Abstract] [Full Text] [Related]
8. Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches. Kimball P; Wagner B; King A; Fisher RA; Dawson S; Cotterell A; Posner M Clin Transplant; 2002 Aug; 16(4):290-4. PubMed ID: 12099986 [TBL] [Abstract][Full Text] [Related]
9. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]
10. Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients. Tsang WK; Tong KL; Yeung S; Lee W; Chan HW Transplant Proc; 2000 Nov; 32(7):1755-6. PubMed ID: 11119921 [No Abstract] [Full Text] [Related]
11. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database. Tsai SF; Cheng CY; Shu KH; Wu MJ Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612 [TBL] [Abstract][Full Text] [Related]
12. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization. Smith JM; Nemeth TL; McDonald RA Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279 [TBL] [Abstract][Full Text] [Related]
13. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. Burke GW; Ciancio G; Alejandro R; Roth D; Ricordi C; Tzakis A; Miller J Transplant Proc; 1998 Jun; 30(4):1544-5. PubMed ID: 9636627 [No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group. Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021 [TBL] [Abstract][Full Text] [Related]
17. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression. Bush WW AACN Clin Issues; 1999 May; 10(2):253-69; quiz 304-6. PubMed ID: 10578712 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients. Suhail SM; Vathsala A; Lou HX; Woo KT Transplant Proc; 2000 Nov; 32(7):1757-8. PubMed ID: 11119922 [No Abstract] [Full Text] [Related]
19. Long-term results of pancreas transplantation under tacrolius immunosuppression. Jordan ML; Shapiro R; Gritsch HA; Egidi F; Khanna A; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ Transplantation; 1999 Jan; 67(2):266-72. PubMed ID: 10075592 [TBL] [Abstract][Full Text] [Related]